Skip to main content

Biosyent Inc(RX-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Biosyent Inc up on Wednesday (RX)

Automated Summaries - The Globe and Mail - Wed May 1, 4:02PM CDT

In trading today, Biosyent Inc opened at $8.68 and closed at $8.69. prices ranged from a low of $8.65 to a high of $8.69.

The price advanced 1.05% from the previous day's close of $8.60.

Today across North America, the TSX Composite closed -1.35% at 21714.54, the S&P 500 closed -1.57% at 5035.69, the Dow Jones Industrial Average closed -1.49% at 37815.92 and the Nasdaq Composite closed -2.04% at 15657.82.

Biosyent Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker RX.

Trading volume was 400 on 4 total trades. On average, Biosyent Inc has traded 5,610 shares over 5 days and 5,923 year-to-date.

The TSX-V market on the whole today saw 3,401 price advancers against 1,804 declines and 97 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, in the last 12 months, Biosyent Inc's shares have advanced 14.34 percent, while this year, they have dipped -5.75%.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $99.81 million on a float of 11,605 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Biosyent Inc's average recommendation is "Moderate Buy" based on 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe